Scientists hunt for clues in Cancer's secret messages
NCT ID NCT02393703
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at tiny particles called exosomes, which carry proteins and genetic material between cells. Researchers will collect blood and tissue from 181 people with pancreatic cancer or noncancerous pancreatic disease to compare exosome activity. The goal is to understand if exosomes are linked to cancer recurrence and to establish normal values for future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify markers to predict pancreatic cancer recurrence or outcomes, paving the way for future diagnostic or treatment studies.
- What could go wrong
- This is an early observational study, not a treatment trial. It may not find clear links between exosomes and disease outcomes, and results may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PANCREATIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Do Younger-Age pancreatic tumors behave differently? a new study digs in
- MRI might reveal hidden pancreatic risks in obesity